{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:25:26Z","timestamp":1793298326618,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T00:00:00Z","timestamp":1521590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Italian Society of Internal Medicine"},{"name":"Ca\u2019 Granda Maggiore Policlinico Hospital Foundation"},{"name":"Mario Negri Institute of Pharmacological Research"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s40266-018-0532-8","type":"journal-article","created":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T04:24:57Z","timestamp":1521606297000},"page":"365-373","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study"],"prefix":"10.1007","volume":"35","author":[{"name":"REPOSI Investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Paciullo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6987-9349","authenticated-orcid":false,"given":"Vanessa","family":"Bianconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Pirro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Mannuccio","family":"Mannucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziana","family":"Lupattelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,21]]},"reference":[{"key":"532_CR1","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1161\/CIR.0000000000000350","volume":"133","author":"D Mozaffarian","year":"2015","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2015;133:e38\u2013360.","journal-title":"Circulation"},{"key":"532_CR2","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1001\/jama.2015.4369","volume":"313","author":"GYH Lip","year":"2015","unstructured":"Lip GYH, Lane DA. Stroke prevention in atrial fibrillation. JAMA. 2015;313:1950\u201362.","journal-title":"JAMA"},{"key":"532_CR3","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S0140-6736(16)31257-0","volume":"388","author":"B Freedman","year":"2016","unstructured":"Freedman B, Potpara TS, Lip GYH. Stroke prevention in atrial fibrillation. Lancet. 2016;388:806\u201317.","journal-title":"Lancet"},{"key":"532_CR4","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/S0140-6736(16)31258-2","volume":"388","author":"IC Gelder Van","year":"2016","unstructured":"Van Gelder IC, Rienstra M, Crijns HJGM, Olshansky B. Rate control in atrial fibrillation. Lancet. 2016;388:818\u201328.","journal-title":"Lancet"},{"key":"532_CR5","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0140-6736(16)31277-6","volume":"388","author":"JP Piccini","year":"2016","unstructured":"Piccini JP, Fauchier L. Rhythm control in atrial fibrillation. Lancet. 2016;388:829\u201340.","journal-title":"Lancet"},{"key":"532_CR6","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(00)03230-X","volume":"356","author":"SH Hohnloser","year":"2000","unstructured":"Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation: pharmacological INTERVENTION IN ATRIAL FIBRILLATION (PIAF): a randomised trial. Lancet. 2000;356:1789\u201394.","journal-title":"Lancet"},{"key":"532_CR7","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jacc.2011.04.030","volume":"58","author":"MD Smit","year":"2011","unstructured":"Smit MD, Crijns HJGM, Tijssen JGP, Hillege HL, Alings M, Tuininga YS, et al. Effect of lenient versus strict rate control on cardiac remodeling in patients with atrial fibrillation data of the RACE II (RAte Control Efficacy in permanent atrial fibrillation II) study. J Am Coll Cardiol. 2011;58:942\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"532_CR8","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1056\/NEJMoa021328","volume":"347","author":"DG Wyse","year":"2002","unstructured":"Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825\u201333.","journal-title":"N Engl J Med"},{"key":"532_CR9","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","volume":"358","author":"D Roy","year":"2008","unstructured":"Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med. 2008;358:2667\u201377.","journal-title":"N Engl J Med"},{"key":"532_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jacep.2015.11.001","volume":"2","author":"A Noheria","year":"2016","unstructured":"Noheria A, Shrader P, Piccini JP, Fonarow GC, Kowey PR, Mahaffey KW, et al. Rhythm control versus rate control and clinical outcomes in patients with atrial fibrillation. JACC Clin Electrophysiol. 2016;2:221\u20139.","journal-title":"JACC Clin Electrophysiol."},{"key":"532_CR11","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1001\/archinternmed.2012.2266","volume":"172","author":"R Ionescu-Ittu","year":"2012","unstructured":"Ionescu-Ittu R, Abrahamowicz M, Jackevicius CA, Essebag V, Eisenberg MJ, Wynant W, et al. Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation. Arch Intern Med. 2012;172:997\u20131004.","journal-title":"Arch Intern Med"},{"key":"532_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00228-010-0977-0","volume":"67","author":"A Nobili","year":"2011","unstructured":"Nobili A, Licata G, Salerno F, Pasina L, Tettamanti M, Franchi C, et al. Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study. Eur J Clin Pharmacol. 2011;67:507\u201319.","journal-title":"Eur J Clin Pharmacol"},{"key":"532_CR13","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","volume":"31","author":"AJ Camm","year":"2010","unstructured":"Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation. Eur Heart J. 2010;31:2369\u2013429.","journal-title":"Eur Heart J"},{"key":"532_CR14","unstructured":"Miller MD, Towers A. A manual of guidelines for scoring the Cumulative Illness Rating Scale for geriatrics (CIRS\/G). Pittsburg, PA: University of Pittsburg; 1991."},{"key":"532_CR15","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1111\/j.1532-5415.2008.01935.x","volume":"56","author":"F Salvi","year":"2008","unstructured":"Salvi F, Miller MD, Grilli A, Giorgi R, Towers AL, Morichi V, et al. A manual of guidelines to score the modified cumulative illness rating scale and its validation in acute hospitalized elderly patients. J Am Geriatr Soc. 2008;56:1926\u201331.","journal-title":"J Am Geriatr Soc"},{"key":"532_CR16","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1176\/ajp.140.6.734","volume":"140","author":"R Katzman","year":"1983","unstructured":"Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short Orientation\u2013Memory\u2013Concentration Test of cognitive impairment. Am J Psychiatry. 1983;140:734\u20139.","journal-title":"Am J Psychiatry"},{"key":"532_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","volume":"17","author":"JA Yesavage","year":"1982","unstructured":"Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17:37\u201349.","journal-title":"J Psychiatr Res"},{"key":"532_CR18","first-page":"61","volume":"14","author":"FI Mahoney","year":"1965","unstructured":"Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61\u20135.","journal-title":"Md State Med J."},{"key":"532_CR19","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/j.1540-8167.2010.01950.x","volume":"22","author":"W Martin-Doyle","year":"2011","unstructured":"Martin-Doyle W, Essebag V, Zimetbaum P, Reynolds MR. Trends in US hospitalization rates and rhythm control therapies following publication of the AFFIRM and RACE trials. J Cardiovasc Electrophysiol. 2011;22:548\u201353.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"532_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12603-015-0444-9","volume":"19","author":"O Hanon","year":"2015","unstructured":"Hanon O, Vidal JS, Pisica-Donose G, Benattar-Zibi L, Bertin P, Berrut G, et al. Therapeutic management in ambulatory elderly patients with atrial fibrillation: the S.AGES cohort. J Nutr Health Aging. 2015;19:219\u201327.","journal-title":"J Nutr Health Aging."},{"key":"532_CR21","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.jamda.2015.05.012","volume":"16","author":"A Wutzler","year":"2015","unstructured":"Wutzler A, von Ulmenstein S, Attanasio P, Huemer M, Parwani AS, Boldt L-H, et al. Treatment of nonagenarians with atrial fibrillation: insights from the Berlin atrial fibrillation (BAF) registry. J Am Med Dir Assoc. 2015;16:969\u201372.","journal-title":"J Am Med Dir Assoc."},{"key":"532_CR22","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1093\/europace\/euw295","volume":"18","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18:1609\u201378.","journal-title":"Europace."},{"key":"532_CR23","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.amjmed.2013.04.021","volume":"126","author":"N Shariff","year":"2013","unstructured":"Shariff N, Desai RV, Patel K, Ahmed MI, Fonarow GC, Rich MW, et al. Rate-control versus rhythm-control strategies and outcomes in septuagenarians with atrial fibrillation. Am J Med. 2013;126:887\u201393.","journal-title":"Am J Med"},{"key":"532_CR24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1365-2125.2005.02449.x","volume":"60","author":"CR Kumana","year":"2005","unstructured":"Kumana CR, Cheung BMY, Cheung GTY, Ovedal T, Pederson B, Lauder IJ. Rhythm vs. rate control of atrial fibrillation meta-analysed by number needed to treat. Br J Clin Pharmacol. 2005;60:347\u201354.","journal-title":"Br J Clin Pharmacol"},{"key":"532_CR25","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1161\/HCQ.0000000000000011","volume":"7","author":"ACT Ha","year":"2014","unstructured":"Ha ACT, Breithardt G, Camm AJ, Crijns HJ, Fitzmaurice GM, Kowey PR, et al. Health-related quality of life in patients with atrial fibrillation treated with rhythm control versus rate control: insights from a prospective international registry (registry on cardiac rhythm disorders assessing the control of atrial fibrillation: RECORD-AF). Circ Cardiovasc Qual Outcomes. 2014;7:896\u2013904.","journal-title":"Circ Cardiovasc Qual Outcomes."},{"key":"532_CR26","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1592\/phco.31.6.552","volume":"31","author":"A Perez","year":"2011","unstructured":"Perez A, Touchette DR, DiDomenico RJ, Stamos TD, Walton SM. Comparison of rate control versus rhythm control for management of atrial fibrillation in patients with coexisting heart failure: a cost-effectiveness analysis. Pharmacotherapy. 2011;31:552\u201365.","journal-title":"Pharmacotherapy."},{"key":"532_CR27","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/eurheartj\/ehw087","volume":"37","author":"L Friberg","year":"2016","unstructured":"Friberg L, Tabrizi F, Englund A, Wyse D, Waldo A, DiMarco J, et al. Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries. Eur Heart J. 2016;37:1825\u201333.","journal-title":"Eur Heart J"},{"issue":"2","key":"532_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/europace\/euw421","volume":"20","author":"Y Purmah","year":"2018","unstructured":"Purmah Y, Proietti M, Laroche C, Mazurek M, Tahmatzidis D, Boriani G, et al. Rate vs. rhythm control and adverse outcomes among European patients with atrial fibrillation. Europace. 2018;20(2):243\u201352.","journal-title":"Europace."},{"key":"532_CR29","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1161\/CIRCULATIONAHA.112.092494","volume":"126","author":"MA Tsadok","year":"2012","unstructured":"Tsadok MA, Jackevicius CA, Essebag V, Eisenberg MJ, Rahme E, Humphries KH, et al. Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation. Circulation. 2012;126:2680\u20137.","journal-title":"Circulation"},{"key":"532_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1076-7460.2005.02281.x","volume":"14","author":"HJ Vidaillet","year":"2005","unstructured":"Vidaillet HJ. Rate control vs. rhythm control in the management of atrial fibrillation in elderly persons. Am J Geriatr Cardiol. 2005;14:73\u201380.","journal-title":"Am J Geriatr Cardiol."}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-018-0532-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-018-0532-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-018-0532-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T20:28:42Z","timestamp":1553113722000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-018-0532-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,21]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["532"],"URL":"https:\/\/doi.org\/10.1007\/s40266-018-0532-8","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,21]]},"assertion":[{"value":"21 March 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The REPOSI study was supported by the Italian Society of Internal Medicine (SIMI), the Ca\u2019 Granda Maggiore Policlinico Hospital Foundation, and the Mario Negri Institute of Pharmacological Research. This study was supported by an unrestricted grand from Pfizer to the Scientific Director of Ca\u2019 Granda Maggiore Policlinico Hospital Foundation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Marco\u00a0Proietti has received a consulting fee from Boehringer Ingelheim. Pier Mannuccio Mannucci has received honoraria for lectures as speaker or chair symposia organized by Bayer, Grifols, Kedrion, LFB, Novo Nordisk and Pfizer, and is a scientific consultant for Bayer, Baxalta and Kedrion. Gregory Y.H. Lip is a consultant for Bayer\/Janssen, BMS\/Pfizer, Biotronik, Medtronic, Boehringer Ingelheim, Microlife and Daiichi-Sankyo, and a speaker for Bayer, BMS\/Pfizer, Medtronic, Boehringer Ingelheim, Microlife, Roche and Daiichi-Sankyo. All other authors have no conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}